Higher Antipsychotic Doses Tied to Increased Risk of Tardive Dyskinesia
Tardive dyskinesia (TD) is a serious, often irreversible movement disorder caused by long-term use of dopamine receptor antagonists, particularly antipsychotics.
Electroconvulsive Therapy for Treatment-Resistant Tardive Dyskinesia and Dystonia: Case Report and Review
This case report presents a 25-year-old female with tardive dyskinesia and tardive dystonia, which were refractory to valbenazine treatment.
Exploring the Link Between Non-DRBD Medications and Tardive Dyskinesia
Tardive dyskinesia (TD) is most commonly linked to long-term use of dopamine receptor blocking drugs (DRBDs), such as antipsychotics. However, there has been some exploration of whether non-DRBD medications, like antidepressants, can also trigger similar movement disorders.
Understanding Drug-Induced Movement Disorders: Risks of Antipsychotics and Anticholinergics
Antipsychotic medications are widely used for psychiatric conditions, but they are associated with significant side effects, including drug-induced movement disorders (DIMDs) like drug-induced parkinsonism, acute dystonia, tardive dyskinesia (TD), and neuroleptic malignant syndrome (NMS).
Advances in Tardive Dyskinesia Diagnosis and Treatment: Early Detection and VMAT2 Inhibitors
The clinical manifestations of tardive dyskinesia (TD) can be disruptive, with common symptoms including choreoathetotic and stereotypic movements, particularly in the mouth, jaw, tongue, and face.
Managing Tardive Syndrome: Diagnosis Challenges and Treatment Approaches
The underlying causes of tardive syndrome (TS) are not entirely understood, but hypotheses suggest dopaminergic receptor hypersensitivity and oxidative stress as potential contributors.
Vocal Cord Dysfunction: A Rare but Severe Complication of Tardive Dyskinesia
In this case report, a 65-year-old female presented with chronic obstructive pulmonary disease, major depressive disorder on risperidone, tardive dyskinesia (TD), and dysphagia presented with worsening shortness of breath.
Managing Tardive Dyskinesia: A Case Study Highlighting Diagnosis, Treatment, and Prevention Strategies
The pathophysiology of tardive dyskinesia (TD) involves prolonged dopamine receptor blockade, leading to receptor supersensitivity and oxidative damage in the striatum.
Managing Painless Legs and Moving Toes Syndrome With Individualized Treatment
Painless legs and moving toes syndrome is a rare movement disorder characterized by semi-continuous, involuntary toe movements without associated pain. This report describes a 48-year-old woman with the condition in the context of chronic neuroleptic use.
